Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

132

...

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01XX44	ZALTRAP	BioTech	Aflibercept - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	5,834,030 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	1,046,598 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	35,658,713 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 10mg	10mg	Tablet	12,966,030 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 50mg	50mg	Tablet	13,090,104 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 100mg	100mg	Tablet	11,610,610 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 10mg week 1, Venetoclax - 50mg week 2, Venetoclax - 100mg week 3&4		Tablet	3,131,943 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 100mg	100mg	Tablet	707,858,935 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 600mg, Trastuzumab - 600mg		Injectable solution	5,348,082 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 1200mg, Trastuzumab - 600mg		Injectable solution	9,700,693 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 600mg, Trastuzumab - 600mg		Injectable solution	326,054,156 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 1200mg, Trastuzumab - 600mg		Injectable solution	591,417,874 L.L
L02AE02	LEUPRO-SANDOZ	G	Leuprorelin acetate - 3.6mg	3.6mg	Implant	11,090,138 L.L
L02AE02	LEUPRO-SANDOZ	G	Leuprorelin acetate - 3.6mg	3.6mg	Implant	11,090,138 L.L
L02AE02	LEUPRO-SANDOZ	G	Leuprorelin acetate - 5mg	5mg	Implant	9,108,032 L.L
L02AE02	LEUPRO-SANDOZ	G	Leuprorelin acetate - 5mg	5mg	Implant	9,108,032 L.L
L02AE02	ELIGARD	B	Leuprorelin acetate - 7.5mg	7.5mg	Injectable powder for solution+diluent	7,199,158 L.L
L02AE02	ELIGARD	B	Leuprorelin acetate - 7.5mg	7.5mg	Injectable powder for solution+diluent	7,199,158 L.L
L02AE02	ELIGARD	B	Leuprorelin acetate - 22.5mg	22.5mg	Injectable powder for solution+diluent	17,678,335 L.L
L02AE02	ELIGARD	B	Leuprorelin acetate - 22.5mg	22.5mg	Injectable powder for solution+diluent	17,678,335 L.L
L02AE02	ELIGARD	B	Leuprorelin acetate - 45mg	45mg	Injectable powder for solution+diluent	38,845,268 L.L
L02AE02	ELIGARD	B	Leuprorelin acetate - 45mg	45mg	Injectable lyophilised powder	38,845,268 L.L
L02AE03	ZOLADEX DEPOT	B	Goserelin (acetate) - 3.6mg	3.6mg	Injectable suspension	8,820,074 L.L
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	14,656,778 L.L
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	35,121,328 L.L
L02AE04	DECAPEPTYL	B	Triptorelin - 0.1mg	0.1mg	Injectable lyophilised powder for solution+diluent	2,366,507 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	13,254,492 L.L
L02AE04	GONAPEPTYL	B	Triptorelin acetate - 0.1mg	0.1mg	Injectable solution	4,637,600 L.L

...

132

...